Human Papilloma Virus Vaccination Among Female Patients Attending French Pediatric Cystic Fibrosis Centers

Rousset‐Jablonski, Christine; Haesebaert, Julie; Denis, Angélique; Reix, Philippe; Llerena, Cathy; Perceval, M.; Touzet, Sandrine; Durieu, I.

doi:10.1016/j.jpag.2020.12.004

Cited by 7 publications

(23 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic search was performed in four databases on 13 September 2023, resulting in 9322 articles; after removing the duplicates, 4206 publications were screened by title and abstract. In total, 133 were assessed for full-text, and 25 [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ] were included in the systematic review and meta-analysis ( Figure 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…Fourteen studies were included in the parent’s level of education comparison (ISCED 0–4 vs. 5–8), with 284,944 guardians and 232,063 vaccinated children [ 17 , 18 , 19 , 20 , 21 , 22 , 24 , 27 , 29 , 30 , 31 , 32 , 33 , 34 ]. The results showed an OR of 0.93, with a 95% CI between 0.79 and 1.09, at a Z of 0.94 and a p = 0.35, with no statistical significance; Random Effects (RE) were used for an I 2 of 93% (see Figure 4 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Vaccine Hesitancy among European Parents—Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis

Achimaș-Cadariu,

Pașca,

Jiboc

et al. 2024

Vaccines

View full text Add to dashboard Cite

Background: Due to low adherence to HPV vaccination programs, the European region struggles with vaccination rates lower than 30% among the targeted population. The present report investigated various socio-demographic and psychological factors influencing European parents’ hesitancy towards vaccinating their children. Methods: As of September 2023, four databases were searched. After applying inclusion criteria, all articles comparing psychological and socio-demographic factors in parents who vaccinate or do not vaccinate their children were included. Results: Twenty-five primary publications met the criteria, totaling 385,460 responders, of which 311,803 want to or have already vaccinated their child, and 73,555 do not wish to do so. Immigrant and employment status, religion, age of parents and the child’s gender seemed to influence their decision to vaccinate their child. Previous experience with vaccines, perceived safety and efficacy and the mother’s previous abnormal CCS results also impacted their decision. The caregivers’ education, gender, civil status, number of children, family history of neoplasia or mother’s CCS attendance did not influence their hesitancy to vaccine. Conclusion: Multiple demographic, social, economic and psychological barriers involved in the parents’ hesitancy to vaccinate their children against the HPV virus were highlighted. Specific at-risk categories that need to be targeted with information, education and vaccination campaigns were identified.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Vaccine Hesitancy among European Parents—Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis

Achimaș-Cadariu,

Pașca,

Jiboc

et al. 2024

Vaccines

View full text Add to dashboard Cite

show abstract

“…Multiple large, international, randomised controlled trials have consistently demonstrated HPV vaccinations are safe and effective for prevention of HPV infections, external genital lesions, abnormal pap smears and high-grade cervical dysplasia. A systematic review evaluating population-level impact of girls-only HPV vaccination programmes observed an 83% decline in HPV-16 and HPV-18 (the strains most associated with cancers), a 51% decline in CIN2+ lesions, and a statistically significant decline in anogenital warts, with greater reductions seen in countries with higher uptake rates 10…”

Section: Discussionmentioning

confidence: 99%

“…In CF, there is limited knowledge on factors associated with HPV vaccine uptake. A recent study of paediatric patients with CF identified healthcare providers’ positive advice and fear of HPV-related disease were the main rationale justifying vaccination uptake, with insufficient knowledge and concerns about potential side effects as barriers 10. At present, no consensus guidelines regarding HPV vaccination specifically prior to lung transplantation exist apart from those in the general population.…”

Section: Discussionmentioning

confidence: 99%

Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients

Thornton

Somayaji

Chú

et al. 2022

Thorax

View full text Add to dashboard Cite

Human papillomavirus (HPV) is the principal risk factor for cervical cancer. Transplant recipients are at a disproportionate risk of HPV complications. We conducted a single-centre, retrospective study of adult female cystic fibrosis (CF) lung transplant recipients between 2008 and 2021. We observed 12 of 34 (35.3%) with ≥1 abnormal pap smear (median age: 26.7 years). Complications included refractory anogenital warts (n=3), vulvectomy (n=2) and cervical cancer (n=4), with two deaths from metastatic disease. None with HPV morbidity was vaccinated. Lung transplant recipients had greater odds of cervical dysplasia relative to controls (OR, 3.98; 95% CI 1.17 to 11.82). CF care providers must prioritise HPV vaccination to attenuate potential future morbidity and mortality.

show abstract

“…66 Among 9-to 17-year-old females attending French pediatric CF centers, 31% had received the HPV vaccine with two-thirds receiving the prescription from their CF center. 67 As people with CF can be considered for organ transplantation and immunosuppression is associated with a heightened risk of cervical dysplasia, routine cervical, and STI screening and HPV vaccination is crucial for this population. 68 Genital candidiasis is also a significant and often distressing problem for both men and women with CF.…”

Section: Sexually Transmitted Infections (Stis) and Genital Candidiasismentioning

confidence: 99%

Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis

West

Kazmerski

Taylor‐Cousar

et al. 2021

Pediatric Pulmonology

View full text Add to dashboard Cite

With improved therapies, people with cystic fibrosis are living longer and healthier lives and increasingly have questions surrounding their sexual and reproductive health. This article will summarize the important issues of which providers should be aware during the lifespan of people with cystic fibrosis, including puberty, adulthood, and menopause.A wide range of sexual and reproductive health topics are addressed such as puberty, transgender and gender nonbinary identities, contraception, sexually transmitted infections, hypogonadism, sexual functioning, cyclical hemoptysis, and urinary incontinence. We discuss gaps in knowledge and current evidence as well as management strategies to optimize care. Our goal is to support providers to enable them to give comprehensive care throughout the lifespan of people with cystic fibrosis.

show abstract

Human Papilloma Virus Vaccination Among Female Patients Attending French Pediatric Cystic Fibrosis Centers

Cited by 7 publications

References 27 publications

Vaccine Hesitancy among European Parents—Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis

Vaccine Hesitancy among European Parents—Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis

Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients

Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis

Contact Info

Product

Resources

About